First record of Larsonella pumilus (Teleostei: Gobiidae) from Japan, with phylogenetic placement of the genus Larsonella

During a survey of deep-sea fauna, using a Remotely Operated Vehicle, a single specimen (21.6 mm in standard length) of Larsonella pumilus (Larson & Hoese, 1980) was collected at a depth of 214 m off the coast of Okinawa Island, Japan. It represents the first record of this species from Japan. The collection site was far deeper than previous reports for this species. This suggests that the main habitat of L. pumilus is deeper than previously recognized and it may explain the paucity of records of this species. As the previously available morphological description of L. pumilus was based on only a single specimen (holotype), this new specimen is described herein. Its morphology corresponds closely to the original description of the holotype, except that faint melanophores are arranged radially around the eyes and scattered on the trunk and the fins. Mitochondrial genome sequences of L. pumilus and 19 related species demonstrate close relationships between L. pumilus and the genus Priolepis. These data also indicate that the genus Priolepis is not monophyletic.journal articl

Direct Supply Chain from Forest to House Builder: A Japanese Business Model

AbstractWe developed a direct supply chain from a forest to a house builder for environment-friendly wooden long-life housing based on the “progressive market-in” method. This business model successfully incorporates the external environmental value of the house into its market price.In this paper, we discuss the direct supply chain business model and its environmental effect in Japan, using a micro approach (for individual economic bodies) and a macro approach for the country

A statistical study of convective and dynamic instabilities in the polar upper mesosphere above Tromsø

We have studied the convective (or static) and dynamic instabilities between 80 and 100 km above Tromsø (69.6° N, 19.2° E) using temperature and wind data of 6 min and 1 km resolutions primarily almost over a solar cycle obtained with the sodium lidar at Tromsø. First, we have calculated Brunt–Väisälä frequency (N) for 339 nights obtained from October 2010 to December 2019, and the Richardson number (Ri) for 210 nights obtained between October 2012 to December 2019. Second, using those values (N and Ri), we have calculated probabilities of the convective instability (N2<0) and the dynamic instability (0≤Ri<0.25) that can be used for proxies for evaluating the atmospheric stability. The probability of the convective instability varies from about 1% to 24% with a mean value of 9%, and that of the dynamic instability varies from 4 to 20% with a mean value of 10%. Third, we have compared these probabilities with the F10.7 index and local K-index. The probability of the convective instability shows a dependence (its correlation coefcient of 0.45) of the geomagnetic activity (local K-index) between 94 and 100 km, suggesting an auroral infuence on the atmospheric stability. The probability of the dynamic instability shows a solar cycle dependence (its correlation coefcient being 0.54). The probability of the dynamic instability shows the dependence of the 12 h wave amplitude (meridional and zonal wind components) (C.C.=0.52). The averaged potential energy of gravity waves shows decrease with height between 81 and 89 km, suggesting that dissipation of gravity waves plays an important role (at least partly) in causing the convective instability below 89 km. The probability of the convective instability at Tromsø appears to be higher than that at middle/low latitudes, while the probability of the dynamic instability is similar to that at middle/low latitudes

Deterioration of high-resolution computed tomography findings predicts disease progression after initial decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone

Background Pirfenidone suppresses the decline of forced vital capacity (FVC) in patients with idiopathic pulmonary fibrosis (IPF). However, IPF progresses in some patients despite treatment. We analyzed patients with meaningful FVC declines during pirfenidone treatment and explored the factors predictive of disease progression after FVC decline. Methods This study was a retrospective, multicenter, observational study conducted by the Okayama Respiratory Disease Study Group. We defined initial decline in %FVC as 5% or greater per 6-month period during pirfenidone treatment. IPF patients who were treated with pirfenidone and experienced an initial decline from December 2008 to September 2017 were enrolled. Results We analyzed 21 patients with IPF. After the initial decline, 4 (19.0%) patients showed improvement in disease, 11 (52.4%) showed stable disease, and 6 (28.6%) showed progressive disease. There was no significant correlation between %FVC reduction on initial decline and subsequent %FVC change (p = 0.475). Deterioration of high-resolution computed tomography (HRCT) findings on initial decline was observed significantly more often in the progressive versus improved/stable disease groups (100% vs 20.0%, p = 0.009). Conclusions We revealed that deterioration of HRCT findings may predict disease progression after the initial decline in %FVC in IPF patients treated with pirfenidone

Nintedanib can be used safely and effectively for idiopathic pulmonary fibrosis with predicted forced vital capacity <= 50%: A multi-center retrospective analysis

Background Nintedanib is a multi-kinase inhibitor approved for idiopathic pulmonary fibrosis (IPF); however, its efficacy and safety for patients with IPF and restricted pulmonary function remain unclear. Therefore, the objective of this study was to determine the efficacy and safety of nintedanib for patients with IPF and forced vital capacity (FVC) ≤ 50%. Methods This was a multi-center retrospective study performed by the Okayama Respiratory Disease Study Group. Patients were allocated into FVC ≤ 50% and FVC > 50% groups based on their predicted FVC. The primary endpoints were FVC changes from baseline after 6 and 12 months. Results 45 patients were eligible for the study. 18 patients had FVC ≤ 50%, and 27 patients had FVC > 50%. Overall, 31 and 19 patients underwent pulmonary function tests at 6 and 12 months after initiating nintedanib, respectively. FVC changes from baseline at 6 and 12 months after initiating nintedanib were comparable between the two groups. Adverse events were seen in all patients, and the rates of patients who discontinued nintedanib were also comparable (38.9% vs. 37.0%, p = 1.000). Multiple regression analysis showed that age and forced expiratory volume in 1 second (FEV1)/FVC were negatively correlated with changes in FVC at 6 months after initiating nintedanib. Conclusions Our data suggest that nintedanib can be a useful agent for IPF patients, including those with a low FVC, and that age and FEV1/FVC are predictive markers for changes in FVC following nintedanib treatment